<DOC>
	<DOCNO>NCT00476905</DOCNO>
	<brief_summary>The goal clinical research study evaluate use image technology call spectral diagnosis . Researchers want find special spectral-diagnosis probe use detect skin cancer .</brief_summary>
	<brief_title>Spectral Diagnosis Cutaneous Malignancy</brief_title>
	<detailed_description>The spectral-diagnosis probe use study use dim pulse light identify feature tissue may relate status skin cancer . The probe shape like catheter , camera end , take picture skin . If agree take part study , ask question age , race , smoke status , status disease may ( diabetes , connective tissue disease , infectious disease ) . It take 5 minute answer question . The study doctor decide lesion suitable image probe . If necessary , hair around lesion ( ) shave trim . The area ( ) skin image clean rub alcohol . As part exam , study doctor use probe measure select area tissue . To perform spectral-diagnosis measurement , probe gently place surface skin . Each select area skin take second image . The probe shine different type light onto skin , collect light reflect skin surface . The light signal store researcher look . Preparing lesion , imaging , collect light signal take 10-15 minute per lesion . After image , biopsy perform lesion study doctor decide need treatment part standard care . After clinic visit , participation study . This investigational study . The image probe commercially available FDA approve . At time , use research . Up 150 patient take part study . All enrol M. D. Anderson .</detailed_description>
	<mesh_term>Skin Neoplasms</mesh_term>
	<criteria>1 . Male Female 18 year age . 2 . Patients undergo examination skin 3 . Patients lesion ( ) one five category : basal cell carcinoma , squamous cell carcinoma , precancer lesion , pigment lesion , benign lesion 4 . Patients whose lesion also warrant biopsy . 5 . Signed informed consent document . 1 . Patients absence skin lesion ( ) one five category . 2 . Patients whose identified lesion need biopsy . 3 . Patients sign inform consent agree participate .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Basal Cell Carcinoma</keyword>
	<keyword>Squamous Cell Carcinoma</keyword>
	<keyword>Pre-Cancer Lesions</keyword>
	<keyword>Pigmented Lesions</keyword>
	<keyword>Benign Lesions</keyword>
	<keyword>Skin Cancer</keyword>
	<keyword>Spectral Diagnosis</keyword>
	<keyword>Optical Spectroscopy</keyword>
</DOC>